scholarly journals Cardiac and pleuropulmonary involvement in Erdheim-Chester disease without bone lesions: A case report

2022 ◽  
Vol 17 (3) ◽  
pp. 525-530
Author(s):  
Rene Epunza Kanza ◽  
Olivier Houle ◽  
Pierre-Luc Simard ◽  
Jonathan St-Gelais ◽  
Catherine Raymond
2009 ◽  
Vol 30 (5) ◽  
pp. 651-654 ◽  
Author(s):  
Aziza Mounach ◽  
Abderrzak Nouijai ◽  
Lahsen Achemlal ◽  
Abdellah El Maghraoui ◽  
Ahmed Bezza

2020 ◽  
Vol 7 (1) ◽  
pp. 22
Author(s):  
Rémie Philippe Elia ◽  
ATALLAH Adnan ◽  
AKIKI Béatrice ◽  
WAKED Hani ◽  
ZEIDAN Marwan ◽  
...  

Erdheim Chester disease is a rare form of non-Langerhans histiocytosis with frequent BRAF V600E mutations. It is mainly characterized by multifocal osteosclerotic bone lesions with or without systemic involvement. The histologic image is consistent with a histiocytic proliferation of foamy cells in a polymorphic background. The main difference from the Langerhans histiocytosis is the immune profile with mainly S100, CD1a, and langerin negative. The overall prognosis is dependent on extraskeletal involvement. Herein, we present a typical presentation of Erdheim Chester disease with a review of the literature.


2015 ◽  
Vol 2015 ◽  
pp. 1-4 ◽  
Author(s):  
E. N. Bulycheva ◽  
V. V. Baykov ◽  
M. I. Zaraĭskiĭ ◽  
G. N. Salogub

Erdheim-Chester disease (ECD) represents a clonal non-Langerhans histiocytosis, which manifests under an extensive variety of clinical symptoms. This creates a challenge for the physician, who is required to recognize and diagnose the disease in the early stages. Despite this considerable challenge, in the last decade there has been a dramatic increase in ECD diagnoses, in most part due to an increasing awareness of this rare disorder. Involvement of the axial skeleton is exclusively uncommon with no official recommendations for the treatment of the bone lesions. Here, we present a case report of a young male patient with isolated lesions of the spine, ribs, and pelvis, who was successfully treated with a combination therapy of alfa-interferon and zoledronic acid.


2011 ◽  
Vol 59 (S 01) ◽  
Author(s):  
HR Mahoozi ◽  
A Zittermann ◽  
K Hakim-Meibodi ◽  
J Gummert ◽  
N Mirow

Orbit ◽  
2016 ◽  
Vol 35 (4) ◽  
pp. 221-226 ◽  
Author(s):  
Helen Merritt ◽  
Margaret L. Pfeiffer ◽  
Karina Richani ◽  
Margaret E. Phillips

2020 ◽  
Vol Volume 13 ◽  
pp. 11689-11695
Author(s):  
Sotirios G Papageorgiou ◽  
Aspasia Divane ◽  
Maria Roumelioti ◽  
Christine Kottaridi ◽  
Anthi Bouchla ◽  
...  

2020 ◽  
Vol 21 ◽  
pp. 100722
Author(s):  
Lívio Pereira de Macêdo ◽  
Ulyscélio Santos Moraes Ferreira ◽  
Yally Dayanne Oliveira Ferreira ◽  
Eduardo Vieira de Carvalho Júnior ◽  
Igor Vilela Faquini ◽  
...  

1999 ◽  
Vol 14 (3) ◽  
pp. 323 ◽  
Author(s):  
Yong Koo Park ◽  
Kyung Nam Ryu ◽  
Bang Huh ◽  
Jae Do Kim

Sign in / Sign up

Export Citation Format

Share Document